Paradoxical Relations Between Depressive Symptoms and Sleep Quality During and After Treatment for Breast Cancer: The Role of Self-Presentation

2011 ◽  
Author(s):  
Christine A. Hovanitz ◽  
Jenny Rademacher ◽  
Laura Roush ◽  
Elyse Lower
2021 ◽  
Vol 12 ◽  
Author(s):  
Liqun Wang ◽  
Jiangping Li ◽  
Yuqi Dang ◽  
Haiyu Ma ◽  
Yang Niu

Objective: There are few studies about the relationship between social capital (SC) and depression among type 2 diabetes mellitus (T2DM) patients, and the mechanism explaining how SC leads to decreased depression is unclear. The current study aims to explore the relationship between SC and depressive symptoms among the T2DM patients in northwest China, with a particular focus on the mediating role of sleep quality.Methods: A cross-sectional study of 1,761 T2DM patients from Ningxia Province was conducted. The Center for Epidemiological Survey Depression Scale (CES-D) and self-report sleep quality questionnaire coupled with the SC scales were administered during the face-to-face survey. The Bootstrap methods PROCESS program is employed to test the mediation model.Results: The prevalence of depressive symptoms among T2DM patients was 24.8%. After controlling for covariates, the SC (r = −0.23, p < 0.001) was negatively correlated with CES-D score; the sleep quality was also negatively correlated with CES-D score (r = −0.31, p < 0.001); and the SC was positively correlated with sleep quality (r = 0.10, p < 0.001). Logistic regression analysis showed that SC was inversely related to the risk of depressive symptoms. Meanwhile, sleep quality was negatively associated with depressive symptoms. Sleep quality has mediated the relationship between SC and depressive symptoms among T2DM patients (explaining 12.6% of the total variance).Conclusions: We elucidated how SC interacted with depressive symptoms through the mediation pathway of sleep quality using a representative sample of the Chinese diabetes patients. The findings indicate that the improvement of SC and sleep quality may help in maintaining mental health among T2DM patients. Hence, clinicians can suggest that patients communicate more with others to improve the SC and, in turn, maintain their health.


2019 ◽  
Vol 16 (5) ◽  
pp. 363-369 ◽  
Author(s):  
Han Zhang ◽  
Qi Zhang ◽  
Tingting Gao ◽  
Yixi Kong ◽  
Zeying Qin ◽  
...  

2020 ◽  
Author(s):  
Kyung-Lak Son ◽  
Dooyoung Jung ◽  
Kwang-Min Lee ◽  
Chan-Woo Yeom ◽  
Kyu-Han Oh ◽  
...  

Abstract The purpose of this longitudinal prospective cohort study was to investigate the role of chronotype in the incidence of chemotherapy-induced peripheral neuropathy (CIPN) among women with breast cancer. A total of 128 subjects with breast cancer awaiting adjuvant chemotherapy without peripheral neuropathy participated in this study. The presence of CIPN was defined as a response of 3 or higher on a peripheral neuropathy subscale in the MD Anderson Symptom Inventory. Candidate psychiatric factors associated with CIPN were assessed, using the Composite Scale of Morningness, the Pittsburgh Sleep Quality Index, and the Hospital Anxiety and Depression Scale. To examine the association between chronotype and CIPN, we built logistic regression models, adjusting for demographic, clinical, and other psychiatric variables. Forty-nine participants received a chemotherapy regimen containing docetaxel, of which 29 (59%) developed CIPN. We performed subgroup analyses of docetaxel-treated participants. The morning chronotype was inversely associated with CIPN (odds ratio, 0.07; confidence interval, 0.01–0.48; p = 0.016) after adjusting for age, BMI, education, alcohol use, smoking, disease stage, sleep quality, depression, and anxiety. Our results suggest that the morning chronotype is a protective factor against the development of CIPN in patients with breast cancer who were treated with docetaxel.


2009 ◽  
Vol 24 (8) ◽  
pp. 965-980 ◽  
Author(s):  
Rajni Banthia ◽  
Vanessa L. Malcarne ◽  
Celine M. Ko ◽  
James W. Varni ◽  
Georgia Robins Sadler

2011 ◽  
Vol 12 (9) ◽  
pp. 832-837 ◽  
Author(s):  
Carl J. Stepnowsky ◽  
Joe J. Palau ◽  
Tania Zamora ◽  
Sonia Ancoli-Israel ◽  
Jose S. Loredo

2021 ◽  
Vol 11 (12) ◽  
pp. 1614
Author(s):  
Hui-Ling Lai ◽  
Chun-I Chen ◽  
Chu-Yun Lu ◽  
Chiung-Yu Huang

Cancer-related treatments may lead to side effects that undermine a patients’ quality of life (QOL). Although cognitive behavioral therapy plus coping management (CBTM) may appear to improve health-related QOL in cancer patients, limited documentation exists on the effectiveness of psychosocial interventions for patients with breast cancer (BC) during recovery. The purpose of this study was to examine the effectiveness of CBTM for sleep quality, anxiety, depression, and health among patients with BC. An experimental study was conducted to assess the efficacy of a CBTM intervention (experimental group = 36, control group = 34). The experimental group received a 12-week CBTM intervention focused on their identity, challenges, the replacement of dysfunctional beliefs, coping skills, relaxation, and rehabilitation exercises, while the control group received usual care. The follow-up evaluations were performed immediately after the intervention (T1), and at one (T2) and three months (T3). The generalized estimating equation (GEE) model showed significant effects from the CBTM intervention over time. The experimental group showed significant improvement in sleep quality, anxiety and depressive symptoms, and significant increases in their mental and physical QOL from baseline, T1, T2, and T3—except for the mental and physical QOL showing no significant change at T3—while the control group receiving usual care showed no changes over time. The results suggest that CBTM increases sleep quality, reduces anxiety and depressive symptoms, and enhances health-related QOL for participants. CBTM is efficacious and can be provided by nurses to enhance patients’ coping skills and consequently improve their QOL.


2021 ◽  
Vol 11 (11) ◽  
pp. 1449
Author(s):  
Ivan Vargas ◽  
Erin Kaye Howie ◽  
Alexandria Muench ◽  
Michael L. Perlis

Social distancing was universally implemented to reduce the spread of the COVID-19 virus. Long-term social distancing can lead to increased feelings of social isolation or dissatisfaction with one’s daily interpersonal interactions, which can subsequently result in reduced psychological health (e.g., greater depression). The present study quantified this association, and the extent to which it was moderated by measures of sleep and physical activity, by surveying 3658 adults (mean age = 46.0 years) from across the United States. Participants answered questions related to their social experiences, sleep, physical activity, and depressive symptoms during the early stages of the pandemic (March–June 2020). Results showed that social isolation and social dissatisfaction were associated with greater depressive symptoms. As predicted, self-reported sleep quality and physical activity moderated these associations, such that lower sleep quality and physical activity exacerbated their effect on depressive symptoms.


Sign in / Sign up

Export Citation Format

Share Document